A stem cell transplant added to Rituxan did not improve survival for MRD-negative MCL patients in their first remission ...
Yi Lin, MD, PhD, hematologist and oncologist, Mayo Clinic, discusses the efficacy of ciltacabtagene autoleucel (cilta-cel) chimeric antigen receptor T-cell therapy vs standard treatments for patients ...
The deal involves the implementation into Limbach Group labs of Noul's automated MiLab instrument that uses microscopy and AI-developed algorithms to analyze samples.
Blood tests to detect low iron levels may be a cost-effective way to diagnose and treat iron deficiency, a new study shows.
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced longer-term data for CASGEVY™ (exagamglogene autotemcel) from global clinical trial ...
Study reveals how socioeconomic factors create barriers to bone marrow transplants for AML patients in disadvantaged ...
Abstracts presented Saturday at the American Society of Hematology in San Diego, California included studies on access to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback